Skip to main content
Clinical Trials/DRKS00033413
DRKS00033413
Not yet recruiting
未知

The Effect of neuromuscular electrical stimulation (NMS) and botulinum neurotoxin on facial movement disorders

Klinik für Neurologie, Universitätsklinikum Jena0 sites40 target enrollmentJanuary 18, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
G24.5
Sponsor
Klinik für Neurologie, Universitätsklinikum Jena
Enrollment
40
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 18, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik für Neurologie, Universitätsklinikum Jena

Eligibility Criteria

Inclusion Criteria

  • – Patients with facial movement disorders, regardless of whether symptoms have improved from previous botulinum toxin injections
  • – The effects of previous treatments, including but not limited to botulinum toxin injection, must have completely resolved at the time of inclusion
  • – Signed and dated consent form from the study participant before carrying out study\-specific measures

Exclusion Criteria

  • – Lack of compliance with the inclusion criteria
  • – Patients suffering from neurodegenerative diseases
  • – Severe depression, i.e. \= 20 according to the Beck Depression Inventory (BDI)
  • – Mental or psychiatric illnesses
  • – Pregnant or breastfeeding women
  • – Carrier of an active medical implant
  • – Known allergies or intolerances to materials used in this study
  • – Concurrent participation in other drug or medical device studies that could affect the results of this clinical trial

Outcomes

Primary Outcomes

Not specified

Similar Trials